You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (360Dx) – Oxford Immunotec reported Tuesday that its fourth quarter revenues increased 5 percent year over year, driven by continued growth in both its tuberculosis and tick-borne disease testing businesses.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.